6 May 2019 - Deborah Wilkes
Archived
Worldwide OTC sales at RB dropped by 9% on a like-for-like basis to GBP470 million (USD603 million) in the first quarter of 2019. The company blamed an "unusually weak cold and flu season across the US and several European markets" plus "associated retailer destocking".
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.